Mirae Asset Global ETFs Holdings’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,862
Closed -$28.6K 3034
2025
Q1
$28.6K Buy
5,862
+234
+4% +$1.41K ﹤0.01% 2937
2024
Q4
$46.9K Sell
5,628
-14,472
-72% -$126K ﹤0.01% 2915
2024
Q3
$209K Sell
20,100
-2,771
-12% -$46.1K ﹤0.01% 2359
2024
Q2
$450K Buy
+22,871
New +$458K ﹤0.01% 1872

Other funds holding BLUE

Mirae Asset Global ETFs Holdings's BLUE Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 5,862 shares — an estimated $28.6K sold.

Mirae Asset Global ETFs Holdings first reported a position in BLUE in Q2 2024 and held it in 4 quarters. The position peaked at $450K in Q2 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 5,862 bluebird bio shares in Q2 2025, an estimated $28.6K.
  • Mirae Asset Global ETFs Holdings first reported a position in bluebird bio in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's bluebird bio position peaked at $450K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.